Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Board Change

11 Aug 2020 07:01

RNS Number : 7110V
Derwent London PLC
11 August 2020
 

Derwent London plc (the "Company")

Board CHANGE

 

Derwent London ("The Company") announces that Simon Silver, Executive Director, has informed the Board of his intention to retire from the Board with effect from 26 February 2021. On stepping down from the Board, Simon will continue to support the business as a consultant, until 31 December 2022.

Simon is the co-founder of Derwent London and has been a Director since 1986. Although Simon will continue to work closely with Derwent London until 2022, the Board wishes to extend its gratitude to him for his dedication and service in developing the Derwent London brand and its reputation for leading progressive design over the past 35 years.

 

John Burns, Chairman, commented: "Simon has evolved the Derwent London brand for over 35 years starting with 4,000 sq ft in Islington to recently completing 380,000 sq ft at 80 Charlotte Street. He has brought cutting edge design to every project with his eye for detail and creativity, making Derwent's buildings exciting and instantly recognisable. As both a colleague and friend he is exceptional. His understanding of the central London office market is outstanding and he has worked extensively to share those skills across the Derwent London team for many years. I am delighted that he has agreed to continue in an advisory role and wish him a long and happy retirement."

 

Paul Williams, Chief Executive, commented: "I would like to add my thanks to Simon for his important contribution over the last 35 years. It has been a privilege to work with him for all this time. I look forward to his continued contribution over the next two years as he works alongside our talented team creating the next generation of office space."

 

ends -

 

 

For further information, please contact:

Derwent London

Tel: +44 (0)20 7659 3000

 

 

Paul Williams, Chief Executive

David Lawler, Company Secretary

Quentin Freeman, Head of Investor Relations

 

Brunswick Group

Tel: +44 (0)20 7404 5959

 

Simon Sporborg

Nina Coad

 

 

 

Further information:

 

The information set out below is provided in accordance with section 430(2B) of the Companies Act 2006.

 

Simon Silver

 

There is no payment for loss of office on Simon Silver ceasing to be a Director. Simon Silver is expected to remain as a Director of the Company until his retirement on 26 February 2021 (the "Retirement Date").

 

Simon Silver will continue to receive his base salary, benefits and bonus for the year ending 31 December 2020. His remuneration will be subject to a pro rata reduction for the period 1 January 2021 to the Retirement Date. For the purposes of Long-Term Incentive Plan awards, Simon Silver has been classified as a good leaver. Accordingly, awards will continue and remain capable of vesting at the normal vesting date. Vesting will depend on the extent to which the performance conditions have been satisfied and will be subject to a pro rata reduction for time served during the vesting period. A two year holding period will apply to any awards that vest.

 

From his Retirement Date, and whilst acting as a consultant, Simon Silver will not be eligible to participate in the Annual Bonus Plan and will not receive any future grants under the Company's Long-Term Incentive Plans.

 

Full details of Simon Silver's remuneration as a Director for the 2020 and 2021 financial years will be included in the relevant Directors' Remuneration Reports.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPMMLTMTJBBLM
Date   Source Headline
12th Aug 20257:00 amRNSInterim Results
5th Aug 20257:00 amRNSNew headlease agreed at 50 Baker Street W1
31st Jul 20254:45 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSDisposal of Francis House SW1 for £55.5m
25th Jul 20257:00 amRNSExtension of £450m Revolving Credit Facility
30th Jun 20254:45 pmRNSTotal Voting Rights
18th Jun 20257:00 amRNSAdobe lease extension and expansion
12th Jun 202511:00 amRNSRedemption of £175 million Convertible Bonds
30th May 20254:45 pmRNSTotal Voting Rights
29th May 202511:15 amRNSHolding(s) in Company
23rd May 20254:05 pmRNS£250m 7-year 5.25% bond issuance
16th May 202512:00 pmRNSResults of 2025 Annual General Meeting
8th May 20257:00 amRNSFirst Quarter Business Update
1st May 202510:00 amRNSAnnual Bondholder Meeting
30th Apr 20254:45 pmRNSTotal Voting Rights
15th Apr 202510:00 amRNSAnnual Financial Report
9th Apr 20253:00 pmRNSAdditional Listing
31st Mar 20254:45 pmRNSTotal Voting Rights
31st Mar 202510:00 amRNSNotice of Q1 2025 Business Update
26th Mar 20251:00 pmRNSDirector/PDMR Shareholding
20th Mar 20254:45 pmRNSBlock listing Interim Review
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
4th Mar 20255:15 pmRNSDirector/PDMR Shareholding
28th Feb 20254:45 pmRNSTotal Voting Rights
27th Feb 20257:00 amRNSResults for the Year Ended 31 December 2024
31st Jan 20254:45 pmRNSTotal Voting Rights
30th Jan 20255:35 pmRNSHolding(s) in Company
27th Jan 20251:30 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS25 Baker Street W1 offices fully pre-let
31st Dec 202412:45 pmRNSTotal Voting Rights
3rd Dec 20247:00 amRNSAcquisition
29th Nov 20244:45 pmRNSTotal Voting Rights
7th Nov 20247:00 amRNSTHIRD QUARTER BUSINESS UPDATE
5th Nov 202412:44 pmRNSHolding(s) in Company
31st Oct 20244:45 pmRNSTotal Voting Rights
23rd Oct 20245:30 pmRNSHolding(s) in Company
16th Oct 202410:30 amRNSDirectorate Change
30th Sep 20244:45 pmRNSTotal Voting Rights
20th Sep 20244:45 pmRNSBlock listing Interim Review
19th Sep 202411:00 amRNSDirector/PDMR Shareholding
17th Sep 202411:03 amRNSHolding(s) in Company
30th Aug 20244:45 pmRNSTotal Voting Rights
23rd Aug 202411:15 amRNSAdditional Listing
8th Aug 20247:00 amRNSHalf-Year Results
31st Jul 20244:45 pmRNSTotal Voting Rights
28th Jun 20244:45 pmRNSTotal Voting Rights
12th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:00 pmRNSDirector/PDMR Shareholding
31st May 20244:45 pmRNSTotal Voting Rights
31st May 202410:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.